Discover a new way to find and share stories you'll love… Learn about Reading Desk

Blog Profile / Pharmalot

Filed Under:Medical / Pharmaceutical
Posts on Regator:5543
Posts / Week:16.9
Archived Since:November 10, 2008

Blog Post Archive

Compounder Strikes Preliminary $100M Deal Over Meningitis Outbreak

More than a year after an outbreak of fungal meningitis was traced to the New England Compounding Center and caused the worst public health crisis in the US in decades, the owners, operators and insurers of the bankrupt compounder have...Show More Summary

What Competition? Actelion Loses Case Over Stifling A Rival Drug

For the second time this year, Actelion has been tagged for questionable behavior toward rivals. In the latest instance, a California state court judge has upheld a $407 million jury award that was made after the drugmaker thwarted plans...Show More Summary

The Affordable Care Act Gives Drugmakers A Boost: CMS

What hath the Affordable Care Act wrought? For drugmakers, there looks to be a big boost in spending on prescription medicines. Projected spending is forecast to grow 5.2 percent next year, compared with 0.6 percent growth in 2013, thanks...Show More Summary

Will FDA Widen Use For The Vasecpa Fish Oil Pill, After All?

In a surprising development that has revived intense speculation over the fate of Amarin, the FDA has delayed any decision about whether to widen an indication for the Vascepa prescription fish oil pill. The move was expected last Friday...Show More Summary

Pharmalot... Pharmalittle... Good Morning

Good morning, everyone, and how are you today? We hope the weekend was relaxing and invigorating, especially for those of you who are resuming something resembling the usual routine this morning. Of course, we recognize this is a holiday break for many - or will be quite shortly - but for now, we are attempting to hunt and gather as we normally do. Show More Summary

Novartis Recalls Millions Of Samples Due To Packaging Glitch

Here is a headache no drugmaker wants to endure. Last July, Novartis began recalling a few million bottles of samples of different medicines that were distributed to physicians, because routine testing determined that a chemical used in shrink wrap packaging was found to leech into some tablets. Show More Summary

European Parliament Brokers Deal For Clinical Trial Transparency

After a months-long push, a deal was reached this week at the European Parliament would require drugmakers and academic researchers to upload all results of their European clinical trials to a publicly accessible database. The move comes...Show More Summary

Merck Fined $21M By French Regulators For Bad Behavior

In response to some bad behavior by the former Schering-Plough, French antitrust regulators have fined the Merck unit about $21 million for a campaign to thwart the introduction of a generic version of the Subutex drug that is used to treat opioid addiction. Show More Summary

Pharmalot... Pharmalittle... The Weekend Nears

And so, yet another working week will soon draw to a close. Not a moment too soon, yes? As always, this is our treasured signal to daydream about weekend plans. Our agenda is rather modest, although we do look forward to spending time not only with our full roster of short people but some of the Pharmalot ancestors. Show More Summary

Continuing Medical Education Deserves More Scrutiny: Study

At a time when increasing scrutiny is applied to funding for continuing medical education, a new study notes that relatively little is known about medical communications companies – the for-profit businesses that exist to provide physicians with up-to-date clinical and scientific information. Show More Summary

The Op-Ed: Antidepressants, Pregnancy & Autism: A Potent Mix

Earlier this year, a study reported a link between antidepressants and autism, the second time in two years that such a relationship has been suggested. This week, a study in The New England Journal of Medicine found that children of...Show More Summary

Bristol-Myers Sells Diabetes JV To AstrZeneca: What The Wags Say

Just 18 months ago, Bristol-Myers Squibb expanded its diabetes franchise by paying $7 billion for Amylin Pharmaceuticals and, simultaneously, broadened a joint venture with AstraZeneca. Now, though, Bristol-Myers is selling its stake...Show More Summary

Did Someone Say Hacker? Congress Probes FDA Over Security Breach

After quietly acknowledging to some 5,000 users that its computer systems were hacked two months ago, the FDA is now under increasing pressure from both drugmakers and members of Congress to conduct an investigation because the pharmaceutical...Show More Summary

Pharmalot... Pharmalittle... Good Morning

Top of the morning to you. A glorious sun is warming the chilly Pharmalot corporate campus this morning, where the official mascots are harassing the wild life, the short people are scurrying off to their houses of learning and we are brewing yet another cup of needed stimulation. Show More Summary

Novartis May Face Criminal Charges In Japan Over Diovan Research

The Japanese Health Ministry may file a criminal complaint against Novartis over the Diovan research scandal, according to reports. Last fall, you may recall, the ministry convened a panel that found the drugmaker should be held responsible...Show More Summary

Whatever Happened To The ADA Request For Data From Pharma?

Last spring, the American Diabetes Association attempted to resolve a burning debate about the safety of various diabetes drugs called GLP-1 inhibitors by asking several drugmakers to release patient-level data that could be used for an independent review. Show More Summary

Supreme Court Rejects Former Biotech CEO Free Speech Argument

After years of battling authorities, W. Scott Harkonen has lost his battle to overturn a 2009 conviction for wire fraud in connection with disseminating false and misleading statements in a press release about clinical trial results for a drug that was sold by a biotech where he had been the ceo. Show More Summary

Another Study Hints At The Death Of The Pharma Sales Rep

Has the pharmaceutical industry finally reached the point where sales reps should be addressed as Willy Loman? A new study suggests the time might be near – 67 percent of physicians say digital media is their preferred source of information...Show More Summary

Pharmalot... Pharmalittle... Good Morning

Hello, everyone, and how are you today? We are quite busy this morning here on the Pharmalot corporate campus, where another chilly wintry landscape can be seen from our perch. As usual, we are fending off the cold with another cup of piping hot stimulation and invite you to join us. Show More Summary

Painful Erections: Another Reason To Worry About ADHD Pills

For parents who worry those ADHD pills may not be appropriate, here is another reason for concern – the FDA has just issued a notice saying methylphenidate products, which include Ritalin and Concerta, may cause prolonged and sometimes painful erections known as priapism. Show More Summary

Copyright © 2011 Regator, LLC